CELforPharma

Active Private limited companyfounded 2005active for 21 yearsJan Mommaertslaan 20, 1831 Machelen (Brab.)KBO/BCE: BE 0871.088.704 subsidiary of LAICO4Growth

CELforPharma

Financial year 2025

Follow Report Compare

Annual accounts 2025

abbreviated format, filed on 03-06-2026, 58 days before the deadline

€149,685

▼ 36.0%

-€10,011

▼ €53,361

-€21,251

▼ €58,842

€489,906

▲ 11.1%

52.1%

▼ 7.7 percentage points

6.86

▼ 0.14

Turnover and EBIT margin are not published. The abbreviated format does not require them. The turnover shown is an estimate from the gross margin.

Turnover ≈ €240,000. Estimated: probably between €190,000 and €310,000.

Balance sheet

balance sheet total €619,947 on 31-12-2025

What the company ownsHow it is paid for

in euro

Position in the sector

Compare with sector

52.1%

Higher than 50% of 10,856 companies in 2025.

6.86

Higher than 83% of 10,478 companies in 2025.

-3.4%

Higher than 12% of 10,725 companies in 2025.

CELforPharma Middle half of the sector 80% of the sector Abbreviated accounts in head offices and management consultancy (NACE 70)

Net result: bottom quarter · Equity: middle half · Balance sheet total: middle half · Working capital: top quarter · Staff: middle half

Staff

€66,855

Staff costs divided by the average number of full-time equivalents.

people who joined people who left

Filed annual accounts

as filed with the National Bank, click a year to choose it

Line	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006
Balance sheet: assets
`20/58`	619,947	575,619	553,747	698,777	732,556	1.1m	1.3m	1.2m	1.1m	782,380	744,894	684,461	497,497	349,162	364,028	263,693	182,876	175,587	243,086	92,660
`21/28`	46,511	61,501	78,062	10,053	6,550	11,928	11,434	24,133	36,126	57,452	73,251	30,974	24,742	9,640	10,805	5,307	2,838	5,884	8,294	5,427
`21`	25,214	36,996	43,918	6,689	0	49	1,319	10,417	19,515	28,369	31,314	-	-	-	-	-	-	-	-	-
`22/27`	21,297	24,505	34,144	3,164	5,950	8,870	7,106	10,961	13,855	26,526	39,781	28,618	22,386	5,816	6,981	2,083	522	3,568	5,978	3,111
`23`	6,872	12,223	17,574	194	631	1,204	1,181	2,440	2,286	9,228	16,755	12,085	2,111	5,816	6,981	2,083	522	3,568	5,978	3,111
`24`	6,107	9,261	12,621	2,054	2,883	339	452	1,529	3,058	7,268	11,477	8,043	10,724	-	-	-	-	-	-	-
`26`	8,319	3,021	3,949	916	2,435	7,327	5,473	6,992	8,511	10,030	11,549	8,490	9,551	-	-	-	-	-	-	-
`28`	-	-	0	200	600	3,009	3,009	2,756	2,756	2,556	2,156	2,356	2,356	3,824	3,824	3,224	2,316	2,316	2,316	2,316
`29/58`	573,436	514,117	475,685	688,724	726,007	1.1m	1.3m	1.1m	1.0m	724,928	671,643	653,488	472,755	339,522	353,222	258,386	180,038	169,703	234,793	87,232
`29`	-	-	-	-	0	32,840	52,840	64,840	80,000	-	-	-	-	-	-	-	-	-	-	-
`291`	-	-	-	-	0	32,840	52,840	64,840	80,000	-	-	-	-	-	-	-	-	-	-	-
`40/41`	104,681	112,652	69,100	182,708	262,806	209,796	177,240	201,810	137,862	133,983	79,319	136,890	114,943	63,738	48,257	43,325	18,425	22,685	99,667	6,157
`40`	81,522	84,576	68,551	143,568	262,535	156,561	143,815	154,026	115,641	133,983	69,865	132,924	111,544	62,161	45,366	38,184	9,597	17,485	90,446	5,869
`41`	23,158	28,076	550	39,140	271	53,235	33,425	47,784	22,221	-	9,455	3,966	3,399	1,577	2,891	5,141	8,828	5,200	9,221	288
`50/53`	265,292	262,953	256,021	250,820	261,069	263,804	260,848	256,068	254,789	253,627	250,845	99,000	-	-	-	-	-	-	-	-
`54/58`	191,285	132,932	144,941	241,751	188,223	573,792	755,919	606,361	533,924	324,216	329,200	404,875	346,836	262,119	282,351	206,223	155,762	141,778	132,774	79,386
`490/1`	12,179	5,580	5,624	13,444	13,909	10,903	10,701	14,460	13,945	13,102	12,279	12,722	10,976	13,665	22,615	8,838	5,852	5,240	2,352	1,689
Balance sheet: equity and liabilities
`10/49`	619,947	575,619	553,747	698,777	732,556	1.1m	1.3m	1.2m	1.1m	782,380	744,894	684,461	497,497	349,162	364,028	263,693	182,876	175,587	243,086	92,660
`10/15`	323,248	344,499	306,909	354,507	353,031	699,972	844,024	713,118	655,246	501,218	418,832	371,798	210,380	182,417	179,262	126,305	120,563	93,266	67,661	33,235
`10/11`	20,000	20,000	20,000	20,000	20,000	20,000	20,000	20,000	20,000	20,000	20,000	20,000	20,000	20,000	20,000	20,000	20,000	20,000	20,000	20,000
`100`	-	-	-	-	-	-	20,000	20,000	20,000	20,000	20,000	20,000	20,000	20,000	20,000	20,000	20,000	20,000	20,000	20,000
`13`	303,248	324,499	286,909	334,507	333,031	444,558	588,610	457,704	399,832	245,804	163,418	163,418	2,000	2,000	2,000	2,000	2,000	2,000	2,000	1,000
`130/1`	-	-	-	0	2,000	2,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-
`130`	-	-	-	-	-	-	2,000	2,000	2,000	2,000	2,000	2,000	2,000	2,000	2,000	2,000	2,000	2,000	2,000	1,000
`1311`	-	-	-	0	2,000	2,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-
`133`	303,248	324,499	286,909	334,507	331,031	442,558	586,610	455,704	397,832	243,804	161,418	161,418	-	-	-	-	-	-	-	-
`14`	-	-	0	0	0	235,414	235,414	235,414	235,414	235,414	235,414	188,380	188,380	160,417	157,262	104,305	98,563	71,266	45,661	12,235
`17/49`	296,699	231,119	246,838	344,270	379,526	403,091	424,960	454,554	401,400	281,162	326,062	312,663	287,117	166,745	184,765	137,387	62,313	82,322	175,425	59,425
`17`	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	27,000
`170/4`	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	27,000
`42/48`	83,530	73,353	126,800	110,866	168,850	209,720	245,174	367,952	251,119	225,532	210,952	164,578	136,853	124,503	117,325	90,932	41,121	27,022	67,325	30,025
`44`	57,450	55,710	71,813	41,769	34,861	76,519	115,306	235,399	72,896	111,105	129,205	82,982	56,588	60,605	62,964	71,801	26,921	16,923	44,073	19,074
`440/4`	57,450	55,710	71,813	41,769	34,861	76,519	115,306	235,399	72,896	111,105	129,205	82,982	56,588	60,605	62,964	71,801	26,921	16,923	44,073	19,074
`46`	1,053	1,053	15,410	-	-	-	-	-	-	-	-	-	2,420	-	-	-	-	-	-	-
`45`	25,005	16,567	39,554	39,074	133,966	77,973	129,868	132,417	178,223	114,428	81,747	80,907	77,845	62,649	53,784	18,814	14,097	10,099	21,715	10,502
`450/3`	6,707	5,266	22,655	19,269	80,430	23,758	45,858	73,707	128,504	87,896	48,582	54,405	55,300	40,654	32,921	5,647	242	1,511	20,977	4,766
`454/9`	18,298	11,301	16,899	19,805	53,536	54,215	84,010	58,709	49,719	26,532	33,165	26,502	22,545	21,996	20,863	13,167	13,856	8,588	738	5,735
`47/48`	24	24	24	30,024	24	55,228	-	136	-	-	-	689	-	1,248	577	317	103	-	1,537	449
`492/3`	213,169	157,766	120,038	233,403	210,675	193,371	179,786	86,602	150,282	55,630	115,110	148,086	150,264	42,242	67,441	46,455	21,192	55,300	108,100	2,400
Income statement
`76A`	0	14,841	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
`9900`	149,685	233,885	248,192	322,500	1.1m	480,684	844,827	599,105	646,739	554,512	468,227	537,725	315,261	248,003	271,053	162,186	167,580	114,164	141,250	75,487
`62`	133,710	166,056	267,125	244,087	611,440	428,051	572,510	458,264	328,531	362,891	341,686	228,741	232,731	226,687	187,162	146,108	118,684	68,626	83,070	44,866
`630`	21,850	21,061	11,173	2,826	2,969	4,399	13,923	14,726	23,622	24,449	22,728	10,093	8,092	5,176	4,011	1,563	3,047	3,974	4,336	2,243
`640/8`	4,137	3,418	4,893	3,435	4,059	1,002	1,002	988	975	1,176	448	548	9,905	927	571	348	348	348	-	-
`66A`	-	0	916	-	-	-	-	-	-	-	-	-	-	1,031	-	-	-	-	-	8
`9901`	-10,011	43,350	-35,915	72,152	469,590	47,232	257,392	125,128	293,612	165,996	103,365	298,344	64,534	15,213	79,309	14,167	45,502	41,216	53,844	28,378
`75/76B`	4,793	6,237	4,721	5,038	6,331	8,482	7,123	12,703	17,180	5,846	9,460	7,671	8,177	5,401	17,298	4,320	2,401	2,744	1,875	1,358
`75`	4,793	6,237	4,721	5,038	6,331	8,482	7,123	12,703	17,180	5,846	9,460	7,671	8,177	5,401	17,298	4,320	2,401	2,744	1,875	1,358
`65/66B`	16,033	11,996	15,822	34,649	21,668	19,353	30,936	20,464	28,622	14,058	17,041	19,560	15,008	7,887	10,362	6,492	4,993	2,567	1,089	2,180
`65`	16,033	11,996	15,822	34,649	21,668	19,353	30,936	20,464	28,622	14,058	17,041	19,560	15,008	7,887	10,362	6,492	4,993	2,567	1,089	2,180
`9903`	-21,251	37,590	-47,016	42,541	454,253	36,362	233,580	117,367	282,170	157,783	95,783	286,454	57,703	11,695	86,244	11,995	42,910	41,392	54,630	27,549
`67/77`	-	0	583	11,064	123,222	18,996	102,674	59,495	128,141	75,397	48,750	125,037	29,739	8,541	33,287	6,253	15,612	15,788	20,204	12,067
`9904`	-21,251	37,590	-47,598	31,476	331,031	17,366	130,906	57,872	154,028	82,386	47,033	161,418	27,964	3,154	52,957	5,742	27,297	25,604	34,426	15,482
`9905`	-21,251	37,590	-47,598	31,476	331,031	17,366	130,906	57,872	154,028	82,386	47,033	161,418	27,964	3,154	52,957	5,742	27,297	25,604	34,426	15,482
Appropriation of the result
`9906`	-21,251	37,590	-47,598	31,476	566,445	252,780	366,320	293,286	389,442	317,800	235,414	349,798	188,380	160,417	157,262	104,305	98,563	71,266	46,661	13,235
`14P`	-	-	-	0	235,414	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
`791/2`	21,251	0	47,598	0	442,558	161,418	-	-	-	-	-	-	-	-	-	-	-	-	-	-
`691/2`	0	37,590	0	1,476	331,031	17,366	130,906	57,872	154,028	82,386	-	161,418	-	-	-	-	-	-	1,000	1,000
`6920`	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,000	1,000
`6921`	0	37,590	0	1,476	331,031	17,366	130,906	57,872	154,028	82,386	-	161,418	-	-	-	-	-	-	-	-
`694/7`	-	-	0	30,000	677,972	161,418	-	-	-	-	-	-	-	-	-	-	-	-	-	-
`694`	-	-	-	0	677,972	161,418	-	-	-	-	-	-	-	-	-	-	-	-	-	-
`695`	-	-	0	30,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Social balance sheet
`9087`	2	2.5	4.2	4.4	7.4	6.7	6.4	5.9	5.4	5.9	6.5	4.7	4.2	3.9	3.2	2.7	2.2	1.6	1.4	1
Hours worked`1013`	3,456	4,125	7,070	6,842	12,729	9,033	11,095	10,377	9,308	10,354	9,609	7,068	6,292	6,211	4,458	4,250	3,444	2,654	2,090	1,702
Document	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF

The accounts for financial year 2005 were filed as a document without figures as data, a scan for example.

The notes to these accounts have 11 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the filed accounts (PDF).

Source: Annual accounts 2025 (PDF), filed on 03-06-2026.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank

Financial year	Type	Filed	Reference	Document
31-12-2025	abbreviated format	03-06-2026	2026-00133999	PDF
31-12-2024	abbreviated format	12-06-2025	2025-00133262	PDF
31-12-2023	abbreviated format	05-06-2024	2024-00109628	PDF
31-12-2022	abbreviated format	08-06-2023	2023-00112841	PDF
31-12-2021	abbreviated format	20-07-2022	2022-20202747	PDF
31-12-2020	abbreviated format	04-06-2021	2021-17500558	PDF
31-12-2019	abbreviated format	27-08-2020	2020-46100167	PDF
31-12-2018	abbreviated format	21-06-2019	2019-21300053	PDF
31-12-2017	abbreviated format	18-06-2018	2018-19700524	PDF
31-12-2016	abbreviated format	08-06-2017	2017-16100587	PDF
31-12-2015	abbreviated format	14-06-2016	2016-17700042	PDF
31-12-2014	abbreviated format	22-06-2015	2015-22100425	PDF
31-12-2013	abbreviated format	27-05-2014	2014-13900424	PDF
31-12-2012	abbreviated format	05-07-2013	2013-27600109	PDF
31-12-2011	abbreviated format	25-06-2012	2012-21100147	PDF
31-12-2010	abbreviated format	15-06-2011	2011-17000462	PDF
31-12-2009	abbreviated format	11-06-2010	2010-16900533	PDF
31-12-2008	abbreviated format	28-05-2009	2009-17100118	PDF
31-12-2007	abbreviated format	13-06-2008	2008-22900074	PDF
31-12-2006	abbreviated format	05-07-2007	2007-35300390	PDF
31-12-2005	abbreviated format	06-06-2006	2006-18500289	PDF

Subsidies and aid

Flemish government 2022 to 2023, 2 entries, €731 awarded, €731 paid

Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)

€731

Year	Entries	Awarded	Paid
2023	1	€287	€287
2022	1	€444	€444

Key figures and ratios

per financial year, computed from the annual accounts

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006
11,839	64,411	-24,742	74,978	472,560	51,631	271,315	139,853	317,233	190,445	126,093	308,436	72,626	20,389	83,320	15,730	48,548	45,190	58,180	30,621
599	58,651	-36,425	34,303	334,000	21,765	144,829	72,598	177,650	106,835	69,762	171,510	36,056	8,331	56,968	7,305	30,344	29,579	38,762	17,725
6,860	4,500	80,297	6,730	-2,409	4,893	1,224	2,733	2,296	8,650	65,206	16,325	26,552	5,042	9,510	4,032	0	1,565	7,202	1,945
58,353	-12,008	-96,811	53,528	-385,570	-182,127	149,559	72,437	209,707	-4,983	-75,676	58,039	84,717	-20,231	76,128	50,461	13,983	9,004	53,388	-
489,906	440,764	348,885	577,857	557,156	881,415	1.0m	775,587	769,402	499,396	460,690	488,910	335,903	215,020	235,897	167,453	138,917	142,681	167,468	57,208
52.1%	59.8%	55.4%	50.7%	48.2%	63.5%	66.5%	61.1%	62.0%	64.1%	56.2%	54.3%	42.3%	52.2%	49.2%	47.9%	65.9%	53.1%	27.8%	35.9%
6.86	7.01	3.75	6.21	4.30	5.20	5.13	3.11	4.06	3.21	3.18	3.97	3.45	2.73	3.01	2.84	4.38	6.28	3.49	2.91
0.92	0.67	0.80	0.97	1.08	0.58	0.50	0.64	0.61	0.56	0.78	0.84	1.36	0.91	1.03	1.09	0.52	0.88	2.59	1.79
-6.6%	10.9%	-15.5%	8.9%	93.8%	2.5%	15.5%	8.1%	23.5%	16.4%	11.2%	43.4%	13.3%	1.7%	29.5%	4.5%	22.6%	27.5%	50.9%	46.6%
-3.4%	6.5%	-8.6%	4.5%	45.2%	1.6%	10.3%	5.0%	14.6%	10.5%	6.3%	23.6%	5.6%	0.9%	14.5%	2.2%	14.9%	14.6%	14.2%	16.7%
0.74	5.37	-1.56	2.16	21.81	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Social balance sheet

Item	31-12-2025	31-12-2024	31-12-2023	31-12-2022	31-12-2021
Employees at the balance-sheet date	2	2	3	4	6
full-time	2	2	3	3	4
part-time	0	0	0	1	2
in full-time equivalents	2	2	3	3.8	5.3
	2	2.5	4.2	4.4	7.4
On a permanent contract	2	2	3	4	6
Joined	-	1	2	1	3
Left	-	2	3	3	5
Training hours	-	-	0	-	-

Source: social balance sheet in the 2021 to 2025 annual accounts

Investments

fixed assets acquired

Item	2025	2024	2023	2022	2021
Tangible fixed assets	€6,860	-	€39,087	-	-
Intangible fixed assets	-	€4,500	€41,210	€6,730	-
	€21,850	€21,061	€11,173	€2,826	€2,969

Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)

Insights on CELforPharma

The operating result for 2025 is a loss of €10,011, after a profit of €43,350 in 2024.

Debt's share of the balance-sheet total rises from 40.2% to 47.9%. Equity is lower and debt is higher.

Next steps

Work out how much credit to give this customer and on what payment terms.Credit check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed

Annual accounts 2025

Balance sheet

Change in equityin euro

Change in cashin euro

Position in the sector

Solvency52.1%

Current ratio6.86

Return on assets-3.4%

Staff

Staff cost per FTE€66,855

Joined and left

Filed annual accounts

Filings

Subsidies and aid

Flemish government 2022 to 2023, 2 entries, €731 awarded, €731 paid

Key figures and ratios

Social balance sheet

Investments

Insights on CELforPharma

Next steps

in euro

in euro

52.1%

6.86

-3.4%

€66,855